Skip to content

Clinical trials

Completed Schizophrenia trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Hungary Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20045
20052
20061
20072
20084
20105
20113
20122
20132
20141
20151
20163
20173
20181
20201
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.8
AstraZeneca6
Janssen-Cilag International NV5
ACADIA Pharmaceuticals Inc.3
Hoffmann-La Roche3
Janssen Research & Development, LLC2
Sumitomo Pharma America, Inc.2
AbbVie1
Boehringer Ingelheim1
Celon Pharma SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia41
Psychotic Disorders3
Mental Disorders2
Autistic Disorder1
Bipolar Disorder1
Cognitive Dysfunction1
Recurrence1
Schizophrenia Spectrum and Other Psychotic Disorders1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.